Uric acid and the vasculature

Current Hypertension Reports

Volumn 8, Issue 2, 2006, Pages 116-119

  Corry, Dalila B ^a   Tuck, Michael L ^b  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; ALLOPURINOL; ANGIOTENSIN II; C REACTIVE PROTEIN; CYCLOOXYGENASE 2; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXYGEN RADICAL; PLACEBO; PLATELET DERIVED GROWTH FACTOR A; THROMBOXANE; URIC ACID; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPERURICEMIA; INSULIN RESISTANCE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URIC ACID BLOOD LEVEL; VASCULAR SMOOTH MUSCLE;

BLOOD VESSELS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERURICEMIA; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE; URIC ACID;

EID: 33744483767     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-006-0006-y     Document Type: Article

References (55)

1. Gertler MM, Garn SM, Levine SA: Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951, 34:1421-1431.
2. Klein R, Klein BE, Cornoni J, et al.: Serum uric acid: it's relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973, 132:401-410.
3. Bengtsson C, Lapidus L, Stendahal C, Waldenstrom J: Hyperuricemia and risk of cardiovascular disease and overall death. Acta Med Scand 1988, 224:549-555.
4. Burack RC, Keller JB, Higgins MW: Cardiovascular risk factors and obesity. J Chronic Dis 1985, 38:865-872.
5. Levine W, Dyer AR, Shekelle RB, et al.: Serum uric acid and 11.5-year mortality of middle-aged women: finding of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989, 42:257-267.
6. Fessel WJ: High uric acid as an indicator of cardiovascular disease. Am J Med 1980, 68:401-404.
7. Staessen J: The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly Trial. Am J Med 1991, 90(Suppl3A):50S.
8. Woo J, Swaminathan R, Cockram C, et al.: Association between serum uric acid and some cardiovascular risk factors in a Chinese population. Postgrad Med J 1994, 70:486-491.
9. Freedman DS, Williamson DF, Gunter EW, Byers T: Relation of serum uric acid to mortality and ischemic heart disease. Am J Epidemiol 1995, 141:637-644.
10. Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death. Ann Intern Med 1999, 131:7-13.
11. The Coronary Drug Project Research Group: Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chronic Dis 1976, 29:557-569.
12. Brand FN, McGee DL, Kannel WB, et al.: Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985, 121:11-18.
13. Allard C, Goulet C: Serum uric acid: not a discriminator of coronary heart disease in men and women. Can Med Assoc 1973, 109:986-988.
14. Myers AR, Epstein FH, Dodge HJ, Mikkelsen WM: The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med 1968, 45:520-528.
15. Reunanen A, Takkunen H, Knekt P, Aromaa A: Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 1982, 668:49-59.
16. Wannamethee SG, Shaper AG, Whincup PH: Serum urate and the risk of major coronary heart disease events. Heart 1997, 78:147-153.
17. Lee J, Sparrow D, Vokonas PS, et al.: Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995, 142:288-294.
18. Rich M: Uric acid: Is it a risk factor for cardiovascular disease? Am J Cardiol 2000, 85:1018-1021.
19. Tykarski A: Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991, 59:364-368.
20. Selby JV, Friedman GD, Quesenberry CPJ: Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990, 131:1017-1027.
21. Feig DI, Johnson RJ: Hyperuricemia in childhood primary hypertension. Hypertension 2003, 42:247-252.
22. Messerli FH, Frohlich ED, Dreslinski GR, et al.: Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Arch Intern Med 1980, 93:817-821.
23. Puig JG, Ruilope LM: Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999, 17:869-872.
24. Ramsay LE: Hyperuricemia in hypertension: role of alcohol. BMJ 1979, 1:653-654.
25. Sánchez-Fructuoso AI, Torralbo A, Arroyo M, et al.: Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant 1996, 11:1775-1780.
26. Galvan AQ, Natali A, Baldi S, et al.: Effect of insulin on uric acid excretion in humans. Am J Physiol 1995, 268:E1-E5.
27. Tsunoda S, Kamide K, Minami J, Kawano Y. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens 2002, 15:697-701.
28. Bonora E, Targher G, Zenere MB, et al.: Relationship of uric acid concentration to cardiovascular risk factors in young men: role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996, 20:975-980.
29. Agamah ES, Srinivasan SR, Webber LS, Berenson GS: Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study. J Lab Clin Med 1991, 118:241-249.
30. Clausen JO, Boerch-Johnson K, Pedersen O: Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur J Endocrinol 1998, 138:63-69.
31. Muscelli E, Natali A, Bianchi S, et al.: Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996, 9:746-752.
32. Perry IJ, Wannamethee SG, Walker MK, et al.: Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995, 310:560-564.
33. Webb DJ: The pharmacology of human blood vessels in vivo. J Vasc Res 1995, 32:2-15.
34. Houston M, Chumley P, Radi R, et al.: Xanthine oxidase reaction with nitric oxide and peroxynitrite. Arch Biochem Biophys 1998, 355:1-8.
35. Farquharson CA, Butler R, Hill A, et al.: Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002, 106:221-226.
36. Doehner W, Schoene N, Rauchhaus M, et al.: Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure. Circulation 2002, 105:2619-2624.
37. Butler R, Morris AD, Belch JJF, et al.: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35:746-751.
38. Newland H: Hyperuricemia in coronary, cerebral and peripheral arterial disease: an explanation. Med Hypotheses 1975, 1:152-155.
39. Kanabrocki EL, Third JL, Ryan MD, et al.: Circadian relationship of serum uric Acid and nitric oxide. JAMA 2000, 238:2240-2241.
40. Bagnati M, Perugini C, Cau C, et al.: When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 1999, 340:143-152.
41. Schlotte V, Sevanian A, Hochstein P, Weithmann KU: Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro. Free Rad Biol Med 1998, 25:839-847.
42. Han L, Kanellis J, Li P, et al.: The evidence for a functional organic anion transporter in vascular smooth muscle cells. Presented at: American Society of Nephrology 35th Annual Meeting and Scientific Exposition. October 30-November 4, 2002; Philadelphia, PA. In Program and Abstracts; 13:329A.
43. Rao GN, Corson MA, Berk BC: Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet derived growth factor A-chain expression. J Biol Chem 1991, 266:8604-8608.
44. Kanellis J, Watanabe S, Li JH, et al.: Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003, 41:1287-1293.
45. Patetsios P, Rodino W, Wisselink W, et al.: Identification of uric acid in aortic aneurysms and atherosclerotic artery. Ann N Y Acad Sci 1996, 800:243-245.
46. Saito I, Saruta T, Kondo K, et al.: Serum uric acid and the renin-angiotensin system in hypertension. J Am Geriatr Soc 1978, 26:241-247.
47. Berk BC, Rao GN: Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size. J Cell Physiol 1993, 154:368-380.
48. Yamamoto K, Eslami P, Matsumoto K, et al.: Uric acid stimulates vascular smooth muscle cell proliferation by stimulating the renin angiotensin system. Presented at: Inter-American Society of Hypertension 15th Scientific Meeting. April 27-30, 2003; San Antonio, TX. In: Program and Abstracts; p. 38.
49. Sanchez-Lozada LG, Tapia Edilia, Avila-Casado C, et al.: Mild hyperuricemia induces glomerula hypertension in normal rats. Am J Physiol 2002, 283:F1105-F1110.
50. Kang DH, Nakagawa T, Feng L, et al.: A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002, 13:2888-2897.
51. Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16:3553-3562.
52. Baker JF, Krisnan E, Chen L, Schumacher HR: Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005, 118:816-826.
53. Waring WS, Adwani SH, Breukels O, et al.: Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 2004, 90:155-159.
54. Erdogan D, Gullu H, Caliskan E, et al.: Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract 2005, 59:1276-1282.
55. Houston M, Estevez A, Chumley P, et al.: Binding of xanthine oxidase to vascular endothelium: kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem 1999, 274:4985-4994.